Brain stem encephalitis is a rare complication of COVID-19

Marc C. Shamier*, Yvette S. Crijnen, Susanne Bogers, Jeroen W. IJpelaar, Juna M. de Vries, Mathieu van der Jagt, Jochem K.H. Spoor, Jan H. von der Thüsen, Marco W.J. Schreurs, Corine H. GeurtsvanKessel, Maarten J. Titulaer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
85 Downloads (Pure)

Abstract

Here, we describe the clinical phenotype of SARS-CoV-2-related CNS disease and evaluate the SARS-CoV-2 antibody index as a tool to differentiate between a direct (viral) and indirect etiology. Out of >4000 hospitalized patients with COVID-19, we included 13 patients with neurological symptoms with suspicion of neuroinflammation. On clinical grounds, eight were classified as having a possible/probable relationship between neurological symptoms and COVID-19. A clinically distinctive phenotype of brainstem and cerebellar symptoms was seen in 6/8 patients. As we found a positive SARS-CoV-2 antibody index in 3/5 patients, indicating specific intrathecal SARS-CoV-2 IgG production, a direct link with SARS-CoV-2 is likely.

Original languageEnglish
Article number578007
JournalJournal of Neuroimmunology
Volume374
DOIs
Publication statusPublished - 15 Jan 2023

Bibliographical note

Publisher Copyright:
© 2022 The Authors

Fingerprint

Dive into the research topics of 'Brain stem encephalitis is a rare complication of COVID-19'. Together they form a unique fingerprint.

Cite this